Business

Ventripoint Announces Non-Brokered Private Placement Pursuant to Listed Issuer Financing Exemption

(TheNewswire) Toronto, Ontario, August 29, 2024 – TheNewswire – V...

articleVentripoint Diagnostics Ltd.August 29, 20243/company/ventripoint-diagnostics-ltd/news/ventripoint-announces-non-brokered-private-placement-pursuant-to-listed-issuer-financing-exemption
Ventripoint Announces Non-Brokered Private Placement Pursuant to Listed Issuer Financing Exemption

About this update from Ventripoint Diagnostics Ltd.

[{"type":"text","content":"Ventripoint Announces Non-Brokered Private Placement Pursuant to Listed Issuer Financing Exemption\n\n\n (TheNewswire)\n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n Toronto, Ontario, August 29,\n2024\n \n\n –\n \n\n TheNewswire –\n \n\n Ventripoint Diagnostics Ltd.\n \n\n (“\n \n\n Ventripoint\n \n\n ” or the “\n \n\n Corporation\n \n\n ”,\nTSXV:VPT)\n \n\n announces, further to its press\nrelease dated August 28, 2024, that it intends to complete, subject to\nTSXV Venture Exchange acceptance, a non-brokered private placement of\nup to CDN$500,000 (the “\n \n\n Offering\n \n\n ”) of units (“\n \n\n Units\n \n\n ”) of the\nCorporation at price of $0.195  per Unit.\n \n\n The\nOffering is being made to purchasers’ resident in Canada, except\nQuebec, pursuant to the listed issuer financing exemption under Part\n5A of National Instrument 45-106\n \n\n Prospectus Exempt\nDistributions\n \n\n (the \"\n \n\n Listed Issuer Financing\nExemption\n \n\n \"). The securities offered under\nthe Listed Issuer Financing Exemption will not be subject to a hold\nperiod in accordance with applicable Canadian securities laws.\n \n\n\n\n There is an offering document related to the Offering\nthat can be accessed under the Company’s profile at www.sedar.com\nand on the Company’s website at Ventripoint.com. Prospective\ninvestors should read this offering document before making an\ninvestment decision.\n \n\n\n\n Each Unit will consist of one common share of the\nCorporation (each, a \"\n \n\n Share\n \n\n \") and one Share purchase warrant of\nthe Corporation (a \"\n \n\n Warrant\n \n\n \"). Each Warrant will entitle the\nholder to purchase one Share (each, a \"\n \n\n Warrant Share\n \n\n \")\nat a price of $0.30 per Warrant Share at any time on or before the\ndate which is 6 months after issuance, subject to adjustment in\ncertain events.\n \n\n\n\n The Corporation may pay cash finder’s fee of up to 4%\nof the gross proceeds of the Offering. Finders may also receive common\nshare purchase warrants (“\n \n\n Finder’s Warrants\n \n\n ”) equal to up to 4% of\nthe aggregate subscription amount in relation to subscribers\nintroduced by the finder, each Finder’s Warrant will be exercisab...

More updates from Ventripoint Diagnostics Ltd.